Search Orphan Drug Designations and Approvals
-
Generic Name: | human monoclonal antibody againt human interleukin 13 (IL-13) |
---|---|
Date Designated: | 10/15/2013 |
Orphan Designation: | Treatment of eosinophilic esophagitis |
Orphan Designation Status: | Designated/Designation Withdrawn or Revoked |
Date Designation Withdrawn or Revoked: | 08/17/2022 |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Novartis Pharmaceuticals Corporaton One Health Plaza East Hanover, New Jersey 07936 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-